(Q34253209)

31 July 2017

1 reference

title

From lipodystrophy syndromes to diabetes mellitus (English)

1 reference

31 July 2017

B I Joffe

1

1 reference

31 July 2017

V R Panz

series ordinal

2

1 reference

31 July 2017

F J Raal

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

357

1 reference

31 July 2017

1379-1381

1 reference

31 July 2017

9266

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Free fatty acids and insulin levels--relationship to leptin levels and body composition in various patient groups from South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

A Gene for Congenital Generalized Lipodystrophy Maps to Human Chromosome 9q34

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Evidence for heterogeneous postbinding defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Beacon: a novel gene involved in the regulation of energy balance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Mouse models of lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Thiazolidinediones: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Unraveling the mechanism of action of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904616-X

7 January 2021

10.1016/S0140-6736(00)04616-X

Identifiers

DOI

1 reference

31 July 2017

1 reference